SCHEMBL26277

SCHEMBL26277

O=S(=O)(c1cccs1)N1CCN(c2ccc(C(O)(CF)C(F)F)cc2)[C@@H](Cn2ccnc2)C1

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCKR Q14397 14/20 0.56
GCK P35557 6/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12089988 0.87 GCK (0.59) GCKRGCK
SCHEMBL19407 0.87 GCK (0.70) GCKRGCK
SCHEMBL16021 0.87 GCK (0.70) GCKRGCK
SCHEMBL12078920 0.87 GCK (0.70) GCKRGCK
SCHEMBL16022 0.87 GCK (0.70) GCKRGCK
SCHEMBL16769 0.86 GCKR (0.76) GCKRGCK
SCHEMBL16197 0.85 GCKR (0.62) GCKRGCK
SCHEMBL16425 0.85 GCKR (0.62) GCKRGCK
SCHEMBL25080 0.85 GCKR (0.52) GCKRGCK
SCHEMBL23692 0.85 GCKR (0.52) GCKRGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed